Delivery Order SPE2DE23D0008-SPE2D625F3MVD
- Not listed
- The U.S. Department of Defense Medical Supply Chain division awarded a $2,814.00 fixed-price delivery order to Allergan USA Inc. (a subsidiary of AbbVie Inc.) on May 30, 2025, for Natrelle Inspira SCF 385CC breast implants with an ultimate completion date of May 30, 2025. The delivery order will be performed in Irvine, California, and includes economic price adjustment provisions. This award was made without a set-aside designation, reflecting Allergan's status as the sole source for this...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $2,607 fixed-price delivery order with economic price adjustment to Allergan USA Inc. for Natrelle Inspira SCF 295CC breast implants, with an ultimate completion date of August 13, 2025. This delivery order represents a child contract under Allergan's larger $13.5 million Indefinite Delivery Vehicle for Natrelle breast implants and surgical devices established on December 8, 2022. The award carries no set-aside designation,...
- The U.S. Department of Defense Medical Supply Chain, operating through the Defense Logistics Agency Troop Support Medical, awarded a $2,814 fixed-price delivery order with economic price adjustment to Allergan USA Inc. for Natrelle Inspira SCX 800cc breast implants. The delivery order, issued on September 11, 2025, with an ultimate completion date of September 25, 2025, represents a child order under one of Allergan's existing Indefinite Delivery Vehicles—specifically a $13.5 million IDV for...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814 fixed-price delivery order for Natrelle Inspira SCM 330cc breast implants by the Defense Logistics Agency (DLA) Troop Support Medical on September 5, 2025. This delivery order, which has no set-aside designation, is a child contract stemming from one of Allergan's larger Indefinite Delivery Vehicles—specifically the $13.5 million Natrelle breast implants and surgical devices IDV established on December 8, 2022. The order is...
- Allergan USA Inc., a subsidiary of AbbVie Inc., received a $2,814 fixed-price delivery order from the Defense Logistics Agency (DLA) Medical Supply Chain on September 16, 2025, for Natrelle Inspira SCF 605CC breast implants. This delivery order, with an ultimate completion date of September 18, 2025, represents a child contract issued without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical devices to federal healthcare systems. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a fixed-price delivery order valued at $3,021.00 for Natrelle Inspira SCLP 300cc breast implants from the Defense Logistics Agency's Medical Supply Chain division. This delivery order, which carries no set-aside designation, was awarded on August 14, 2025, with an ultimate completion date of August 18, 2025, and will be performed at Allergan's facility in Irvine, California. The award reflects Allergan's status as a sole-source...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order on September 11, 2025, for Natrelle Inspira SCX 495CC breast implants, with a completion date of September 15, 2025. The contract was awarded without a set-aside designation and is being performed in Irvine, California. This delivery order is funded through the Defense Logistics Agency's Medical Supply Chain division, which oversees procurement of specialized medical devices for the Department of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $3,021 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for Natrelle Inspira SCF 415CC breast implants. The contract, which carries no set-aside designation, reflects Allergan's status as a sole-source provider of specialized reconstructive and aesthetic surgical devices to the federal government. The award is structured as a fixed-price contract with economic price adjustment, with performance...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, with an ultimate completion date of July 24, 2025. The contract covers the supply of Natrelle Inspira SCM 375CC breast implants and will be performed in Irvine, California. This award was made without set-aside designation, reflecting Allergan's position as a specialized supplier of these medical devices to federal...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,495.00 fixed-price delivery order to Allergan USA Inc. on September 15, 2025, for Natrelle TE Smooth 133S-MX-12-T breast implants, with performance completion targeted for September 17, 2025. This delivery order, issued without set-aside designation, represents a child order under one of Allergan's two significant Indefinite Delivery Vehicles established with DLA Troop Support Medical in December 2022—specifically the $13.5 million...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D625F3MVDDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $2,607.00 fixed-price delivery order to Allergan USA Inc. on September 15, 2025, for Natrelle Inspira SCM 520CC breast implants. The delivery order, which has no set-aside designation, represents a child award under one of Allergan's two significant Indefinite Delivery Vehicles with DLA Troop Support Medical—specifically the $13.5 million IDV for Natrelle breast implants and surgical devices established on December 8, 2022. Allergan USA Inc., a subsidiary of AbbVie Inc., serves as the sole-source provider of specialized breast implant devices to federal healthcare systems, including military treatment facilities, Veterans Affairs hospitals, and Indian Health Service centers. The pricing structure utilizes a fixed-price format with economic price adjustment provisions, consistent with Allergan's other federal contract awards. Performance is scheduled to be completed by September 17, 2025, at the vendor's facility in Irvine, California. This delivery order supports reconstructive and aesthetic surgical procedures across Department of Defense research centers, hospitals, and clinics, with product support provided by Allergan representatives to ensure timely availability of these critical medical devices for federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/15/25 |